Comparison of Fumaric Acid 5% Cream Versus Triamcinolone 0.1% Cream in the Treatment of Hand Eczema
,
Abstract
Hand eczema is a common distressing skin problem. It is an immune reaction to haptens. Thus, substances that inhibit Immune system can be effective in the treatment of hand eczema. In this study, topical fumaric acid 5% cream is compared with topical steroid in the treatment of hand eczema. Patients with hand eczema were randomly divided into two groups. One group received fumaric acid 5% in a cream base, and the other received triamcinolone 0.1% in the same cream base. Both groups used creams twice daily for one month. Patients were checked for erythema, excoriation, population and lichenification, EASI score, and pruritus before and after treatment. In both groups, the mean of all signs of the disease and EASI score decreased after one month of treatment. There was no significant difference between the two treatments in decreasing erythema, but excoriation, population, lichenification, EASI score and itching were all decreased more in triamcinolone 0.1 % group. Although fumaric acid can inhibit the immune system; it was less effective for the treatment of all signs of hand eczema except erythema in comparison to triamcinolone. These results may be justified for two reasons: low penetration of topical fumaric acid through the skin or a low concentration used in this study.
Holden CA, Berth–Jones J. Eczema, Lichenification, prurigo and erythroderma. In: Burns T, Breathnach S, Cox N, et al, editors. Rook's text book of Dermatology. 7th ed. Oxford: Blackwell; 2004: p. 699-754.
Funke U, Fartasch M, Diepgen TL. Incidence of workrelated hand eczema during apprenticeship: First results of apropective cohort study in the car industry. Contact Dermatitis 2001;44(3):166-72.
Diepgen TL. Occupational skin-disease data in Europe. Int Arch Occup Environ Health 2003;76(5):331-8.
Bryld LE, Hindsberyer C, Kyvik KO, et al. Risk Factors influencing the development of hand eczema in a population-based twin sample. Br J Dermatol 2003;149(6):1214-20.
Diepgen TL, Agner T, Aberer W, et al. Management of hand eczema. Contact Dermatitis 2007;57(4):203-10.
Lehmann M, Risch K, Nizze H, et al. Fumaric acid estersare potent immunosuppressants: inhibition of acute andchronic rejection in rat kidney transplantation models by methyl hydrogen fumarate. Arch Dermatol Res 2002;294(9):399-404.
Zhu K, Mrowietz U. Inhibition of dendritic cell differentiation by fumaric acid esters. J invest Dermatol 2001;116(2):203-8.
Jowkar F, Jamshidzadeh A, Mirzadeh Yazdi A, et al. The effects of fumaria parviflora L extract on chronic handb eczema: a randomized double-blind placebo controlled clinical trial. Iran Red Crescent Med J 2011;13(11):824-8.
Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in
Litjens NH, Rademaker M, Ravensbergen B, et al. Monomethyle Fumarate effect polarization of monocyte derived dendritic cells. Resulting in down regulated the Lymphocyte responses. Eur J Immunol 2004;34(2):565-75.
Breuer K, Gutzmer R, Volker B, et al. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters. Br J Dermatol 2005;152(6):1290-5.
Gehring W, Gloor M. Persistent Spontaneous erythema caused by topical use of fumaric acid monoetylester – an obligate mast cell degranulation? Dermatol Monatsschr 1990;176(2-3):123-8.
Ducker P, Pfeiff B. Two cases of side effects of a Fumaric acid ester--local therapy. Z Hautkr 1990;65(8):734-36.
Berth-Jones J. Topical Therapy. In: Burns T, Breathnach S, Cox N, et al, editors. Rook's text book of Dermatology. 7th ed. Oxford: Blackwell; 2004: P. 3965-4016.
| Files | ||
| Issue | Vol 52, No 7 (2014) | |
| Section | Articles | |
| Keywords | ||
| Hand eczema Fumaric acid Triamcinolone Immune System | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
